Praxis Precision Medicines, Inc. PRAX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s accounts payable?
- Praxis Precision Medicines, Inc. (PRAX) reported accounts payable of $31.16M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s accounts payable changed year-over-year?
- Praxis Precision Medicines, Inc.'s accounts payable increased by 36.0% year-over-year, from $22.91M to $31.16M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s accounts payable has grown at a 43.2% compound annual growth rate (CAGR), from $4.09M to $24.63M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods or services received.
- How do you interpret accounts payable?
- An increase can signal improved cash management by delaying payments, while a decrease may indicate faster settlement of obligations.
- How does accounts payable compare across companies?
- Standard across all industries; levels are typically proportional to the volume of outsourced research and operational services.